ok, here is a hypothetical , page-5

spendit, they would have to disclose any involvement of a big pharma but only when the deal is done.

A big pharma may want to provide scientific supervision; they may want to change the end points; they may wish to increase the number of patients. All of this would cost money, which the pharma would cover and would make an up-front payment to BLT. When these terms have been worked out, an ASX announcement would follow.

In this hypothetical, if there was such a deal waiting in the wings, there would be no need to worry too much about the current sp or making other positive announcements as big pharma involvement would trump all other news.

Anything is possible in a hypothetical.